700 related articles for article (PubMed ID: 27879486)
1. Prospective interventional study of tenofovir in pregnancy to prevent vertical transmission of hepatitis B in highly viremic women.
Sellier PO; Maylin S; Berçot B; Chopin D; Lopes A; Simoneau G; Evans J; Delcey V; Bénifla JL; Simon F; Bergmann JF
Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):259-263. PubMed ID: 27879486
[TBL] [Abstract][Full Text] [Related]
2. Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers.
Chang KC; Chang MH; Lee CN; Chang CH; Wu JF; Ni YH; Wen WH; Shyu MK; Lai MW; Chen SM; Hu JJ; Lin HH; Hsu JJ; Mu SC; Lin YC; Liu CJ; Chen DS; Lin LH; Chen HL;
Aliment Pharmacol Ther; 2019 Aug; 50(3):306-316. PubMed ID: 31271463
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection.
Celen MK; Mert D; Ay M; Dal T; Kaya S; Yildirim N; Gulsun S; Barcin T; Kalkanli S; Dal MS; Ayaz C
World J Gastroenterol; 2013 Dec; 19(48):9377-82. PubMed ID: 24409065
[TBL] [Abstract][Full Text] [Related]
4. Short article: Hepatitis B virus status in children born to HIV/HBV coinfected women in a French hospital: a cross-sectional study.
Sellier PO; Schnepf N; Amarsy R; Maylin S; Lopes A; Mazeron MC; Flateau C; Morgand M; Ciraru-Vigneron N; Berthe A; Simoneau G; Evans J; Souak S; Matheron S; Benifla JL; Simon F; Bergmann JF
Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):328-32. PubMed ID: 26709883
[TBL] [Abstract][Full Text] [Related]
5. Clinical course of 161 untreated and tenofovir-treated chronic hepatitis B pregnant patients in a low hepatitis B virus endemic region.
Samadi Kochaksaraei G; Castillo E; Osman M; Simmonds K; Scott AN; Oshiomogho JI; Lee SS; Myers RP; Martin SR; Coffin CS
J Viral Hepat; 2016 Jan; 23(1):15-22. PubMed ID: 26192022
[TBL] [Abstract][Full Text] [Related]
6. Telbivudine prevents vertical transmission of hepatitis B virus from women with high viral loads: a prospective long-term study.
Wu Q; Huang H; Sun X; Pan M; He Y; Tan S; Zeng Y; Li L; Deng G; Yan Z; He D; Li J; Wang Y
Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1170-6. PubMed ID: 25251571
[TBL] [Abstract][Full Text] [Related]
7. Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.
Jourdain G; Ngo-Giang-Huong N; Harrison L; Decker L; Khamduang W; Tierney C; Salvadori N; Cressey TR; Sirirungsi W; Achalapong J; Yuthavisuthi P; Kanjanavikai P; Na Ayudhaya OP; Siriwachirachai T; Prommas S; Sabsanong P; Limtrakul A; Varadisai S; Putiyanun C; Suriyachai P; Liampongsabuddhi P; Sangsawang S; Matanasarawut W; Buranabanjasatean S; Puernngooluerm P; Bowonwatanuwong C; Puthanakit T; Klinbuayaem V; Thongsawat S; Thanprasertsuk S; Siberry GK; Watts DH; Chakhtoura N; Murphy TV; Nelson NP; Chung RT; Pol S; Chotivanich N
N Engl J Med; 2018 Mar; 378(10):911-923. PubMed ID: 29514030
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of tenofovir disoproxil fumarate to prevent vertical transmission in mothers with lamivudine-resistant HBV.
Wang J; Liu J; Qi C; Yan T; Cao F; Jin L; He Y; Yang Y; Zhang S; Chen T; Zhao Y
Antivir Ther; 2015; 20(7):681-7. PubMed ID: 26215771
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B Virus (HBV) Variants in Untreated and Tenofovir Treated Chronic Hepatitis B (CHB) Patients during Pregnancy and Post-Partum Follow-Up.
Virine B; Osiowy C; Gao S; Wang T; Castillo E; Martin SR; Lee SS; Simmonds K; van Marle G; Coffin CS
PLoS One; 2015; 10(10):e0140070. PubMed ID: 26474400
[TBL] [Abstract][Full Text] [Related]
10. Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load.
Pan CQ; Duan Z; Dai E; Zhang S; Han G; Wang Y; Zhang H; Zou H; Zhu B; Zhao W; Jiang H;
N Engl J Med; 2016 Jun; 374(24):2324-34. PubMed ID: 27305192
[TBL] [Abstract][Full Text] [Related]
11. [Identification of risk factors related to the failure of immunization to interrupt hepatitis B virus perinatal transmission].
Yin YZ; Zhou J; Zhang PZ; Hou HY
Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):105-10. PubMed ID: 23663881
[TBL] [Abstract][Full Text] [Related]
12. Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.
Jourdain G; Ngo-Giang-Huong N; Cressey TR; Hua L; Harrison L; Tierney C; Salvadori N; Decker L; Traisathit P; Sirirungsi W; Khamduang W; Bowonwatanuwong C; Puthanakit T; Siberry GK; Watts DH; Murphy TV; Achalapong J; Hongsiriwon S; Klinbuayaem V; Thongsawat S; Chung RT; Pol S; Chotivanich N
BMC Infect Dis; 2016 Aug; 16():393. PubMed ID: 27506549
[TBL] [Abstract][Full Text] [Related]
13. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province].
Zhang BF; Cheng ML; Zhang Q; Zhao XK; Yu L; Yang J; Deng KS; Zhang LS; Wang J; Hu YX
Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):945-950. PubMed ID: 30669789
[No Abstract] [Full Text] [Related]
14. Comparison of the efficacy and safety of tenofovir and telbivudine in interrupting mother-to-child transmission of hepatitis B virus.
Zhu B; Lv X; Zhao Z; Chen L; Chen X; Li C; Li S; Dai E
Medicine (Baltimore); 2021 Nov; 100(44):e27695. PubMed ID: 34871254
[TBL] [Abstract][Full Text] [Related]
15. Tenofovir rescue therapy in pregnant females with chronic hepatitis B.
Hu YH; Liu M; Yi W; Cao YJ; Cai HD
World J Gastroenterol; 2015 Feb; 21(8):2504-9. PubMed ID: 25741161
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus.
Chen HL; Lee CN; Chang CH; Ni YH; Shyu MK; Chen SM; Hu JJ; Lin HH; Zhao LL; Mu SC; Lai MW; Lee CL; Lin HM; Tsai MS; Hsu JJ; Chen DS; Chan KA; Chang MH; ;
Hepatology; 2015 Aug; 62(2):375-86. PubMed ID: 25851052
[TBL] [Abstract][Full Text] [Related]
17. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection.
Han GR; Cao MK; Zhao W; Jiang HX; Wang CM; Bai SF; Yue X; Wang GJ; Tang X; Fang ZX
J Hepatol; 2011 Dec; 55(6):1215-21. PubMed ID: 21703206
[TBL] [Abstract][Full Text] [Related]
18. #38: Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission.
; Dionne-Odom J; Tita AT; Silverman NS
Am J Obstet Gynecol; 2016 Jan; 214(1):6-14. PubMed ID: 26454123
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of quantitative hepatitis B virus surface antigen testing in pregnancy in predicting vertical transmission risk.
Samadi Kochaksaraei G; Congly SE; Matwiy T; Castillo E; Martin SR; Charlton CL; Coffin CS
Liver Int; 2016 Nov; 36(11):1604-1610. PubMed ID: 27059287
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of hepatitis B surface antigen in pregnant women with and without tenofovir disoproxil fumarate.
Chang HL; Wen WH; Lee CN; Chiu YE; Liu CJ; Chang MH; Lin LH; Chen HL
J Viral Hepat; 2022 Feb; 29(2):107-114. PubMed ID: 34724288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
